Lataa...
Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical review
Conventional disease-modifying antirheumatic drugs such as methotrexate are the mainstay of treatment for rheumatoid arthritis. More recently, biologic agents such as etanercept, infliximab and adalimumab, which act by inhibiting tumour necrosis factor (TNF), have become available. TNF inhibitors ha...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2669237/ https://ncbi.nlm.nih.gov/pubmed/19368701 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar2666 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|